Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2003
07/24/2003WO2003060073A2 An in vivo protein screen based on enzyme-assisted chemically induced dimerization ('cid')
07/24/2003WO2003060070A2 Method of identifying novel proteins
07/24/2003WO2003060065A2 Adapter-directed display system
07/24/2003WO2003059946A2 Genetic polymorphisms predicting cardiovascular disease and medication efficacy
07/24/2003WO2003059944A2 Gb virus b based replicons and replicon enhanced cells
07/24/2003WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
07/24/2003WO2003059930A1 Detection of a genetic predisposition to cancers and non-cancerous pathologies in mammals
07/24/2003WO2003059929A1 Heteroconfigurational polynucleotide and methods of use
07/24/2003WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins
07/24/2003WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof
07/24/2003WO2003059877A2 Novel affinity labels
07/24/2003WO2003059518A1 An assay device and method for chemical or biological screening
07/24/2003WO2003059516A1 Reaction vessel for carrying out array processes
07/24/2003WO2003059290A2 Diagnostic and therapeutic uses of topors
07/24/2003WO2003059285A2 Rip2: a method of signaling in the innate and adaptive immune systems
07/24/2003WO2003059256A2 Genes overexpresses by ovarian cancer and their use in developing novel therapeutics especially antibodies
07/24/2003WO2003059252A2 Use of a novel cell surface protease from group b streptococcus
07/24/2003WO2003059155A2 Method of detecting t-cell proliferation for diagnosis of diseases by gene array
07/24/2003WO2003059148A2 Gene expression profiles in stomach cancer
07/24/2003WO2003046200A3 Methods for ligand discovery
07/24/2003WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same
07/24/2003WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways
07/24/2003WO2003042406A3 Method for characterising and/or identifying active mechanisms of antimicrobial test substances
07/24/2003WO2003028647A3 Identification of genes involved in restenosis and in atherosclerosis
07/24/2003WO2003022989A3 Therapeutic agents that inhibit the tup1 pathway
07/24/2003WO2003020927A3 Creation of artificial internal ribosome entry site (ires) elements
07/24/2003WO2003018612A3 Extracellular messengers
07/24/2003WO2003016866A3 Method for the enumeration of mammalian micronucleated erythrocyte populations with a single-laser flow cytometer
07/24/2003WO2003012061A3 Methods and compositions relating to plasmacytoid dendritic cells
07/24/2003WO2003011895A3 Compositions and methods for modulation of immune responses
07/24/2003WO2003010289A3 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
07/24/2003WO2003008561A3 Genes associated with benign prostatic hyperplasia
07/24/2003WO2003006948A3 Surface plasmon resonance imaging of micro-arrays
07/24/2003WO2003002528A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
07/24/2003WO2002103059A3 Innate immunity markers for rapid diagnosis of infectious diseases
07/24/2003WO2002099128A3 Sequence independent identification of viruses
07/24/2003WO2002099057A3 Sams modifiers of the p53 pathway and methods of use
07/24/2003WO2002090531A3 Peptidylarginine deiminase 6
07/24/2003WO2002086511A3 Method for testing samples containing prion protein for the possible presence of the prpsc form
07/24/2003WO2002086107A3 A method for differentiating stem cells into insulin-producing cells
07/24/2003WO2002070645A3 Functional surface display of polypeptides
07/24/2003WO2002066960A3 Drug discovery system with auto-sampler for multicellular organisms in a sorting flow cytometer
07/24/2003WO2002061145A3 Competitive amplification of fractionated targets from multiple nucleic acid samples
07/24/2003WO2002061137A3 Compositions and methods for enhancing polynucleotide amplification reactions
07/24/2003WO2002061127A3 Arrayed polynucleotides and their use in genome analysis
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003WO2002059323A3 Aminoacyl trna synthetases
07/24/2003WO2002059300A3 Double-stranded rna-mediated gene suppression
07/24/2003WO2002055718A3 Assembly and screening of highly complex and fully human antibody repertoire in yeast
07/24/2003WO2002055534A3 Haplotypes of the f2rli gene
07/24/2003WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
07/24/2003WO2002052018A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/24/2003WO2002048676A9 Multiple array system for integrating bioarrays
07/24/2003WO2002044417A3 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
07/24/2003WO2002036791A3 Nucleus export reporter system
07/24/2003WO2002028410A9 Perilipin as a target for regulation of body weight, muscle mass and diabetes
07/24/2003WO2002023197A3 Methods and compositions for glycosidase assays
07/24/2003WO2002018645A3 5t4 rna in plasma and serum as a marker for neoplastic disease
07/24/2003WO2002012562A3 Haplotypes of the pla2g1b gene
07/24/2003WO2002006537A3 Methods of identifying renal protective factors
07/24/2003US20030140379 Novel DNA sequences in plant Caragana jubata with freeze tolerance and a method thereof
07/24/2003US20030140370 Fungal glyoxal oxidases
07/24/2003US20030140362 Transgenic rodent implanted with virally infected cells and capable of propagating/replicating virus for detection and monitoring effectiveness of viricides such as antisense agents, lamivudine and interferons
07/24/2003US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening
07/24/2003US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
07/24/2003US20030139581 Protocadherin materials and methods
07/24/2003US20030139573 Lipid binding protein 3
07/24/2003US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds
07/24/2003US20030139363 Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals
07/24/2003US20030139330 Transcription factors containing two potential dna binding motifs
07/24/2003US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030139328 Complexing; modulating biological activation
07/24/2003US20030139327 Nucleic acids, proteins, and antibodies
07/24/2003US20030139325 Complex comprising OCIF and polysaccharide
07/24/2003US20030139324 Cancer diagnosis, therapy; genetic engineered polypeptide
07/24/2003US20030138962 Analyzing method of a blood coagulation reaction
07/24/2003US20030138941 Sample preparation integrated chip
07/24/2003US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening
07/24/2003US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents
07/24/2003US20030138928 Nucleotide sequences coding cyclin-dependent kinase inhibitors for diagnosing sensitivity to cell proliferative disorders; restriction length polymorphisms; gene expression inhibition; anticarciogenic agents; immunoassays
07/24/2003US20030138927 Nucleic acid molecules encoding enzymes having fructosyl polymerase activity
07/24/2003US20030138926 Novel polynucleotides and polypeptides encoded thereby
07/24/2003US20030138925 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
07/24/2003US20030138923 Targeted system for removing tumor cells from cell populations
07/24/2003US20030138922 Therapy of stealth virus associated cancers and other conditions using magnetic energy
07/24/2003US20030138917 Cornyform bacterium polynucleotide coding enzyme with glucose 6-phosphate dehydrogenase activity for increasing biosynthesis of lysine; animal feeds
07/24/2003US20030138911 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
07/24/2003US20030138906 Fluorescence test for measuring heterotrophic bacteria in water
07/24/2003US20030138895 Drug metabolizing enzymes
07/24/2003US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138879 Phosphopantetheinyl transferases and uses thereof
07/24/2003US20030138876 Method bacterial endospore quantification using lanthanide dipicolinate luminescence